U

Ultragenyx Pharmaceutical

Develops and commercializes rare-disease therapies

Environmental Health and Safety Intern

Environmental Health & SafetyPosted on Nov 12
Internship · Summer 2027Bedford, MA, USA

About the Job

Requirements

  • A Bachelor of Science or Bachelor of Arts degree in a technical discipline such as Safety, Environmental, Life Sciences, Engineering, or a similar field is required.
  • Zero to one year of experience in the Environmental, Health, and Safety field is required.
  • Strong communication and organizational skills are required.
  • Creative problem-solving capabilities are required.

Responsibilities

  • Draft, deliver, and support Environmental, Health, and Safety department communications, including safety alerts, events, and training.
  • Assist with EHS Insight data management, including incident investigations, hazard reporting, inspections, corrective actions, and compliance tasks.
  • Assist in coordinating and executing emergency response activities, including evacuation, medical, spill response, and business continuity.
  • Assist with contractor management oversight, including developing Job Hazard Analyses and safe work permits.
  • Collaborate with Facilities and Quality Control stakeholders regarding inspection findings and corrective action planning.
  • Support a fast-paced work environment with many tasks and shifting priorities.
  • Support Environmental, Health, and Safety compliance activities related to the Gene Therapy Manufacturing Facility and Quality Control laboratories.
  • Support site inspections, data management, metric reporting, and continuous improvement projects.
  • Gain hands-on experience supporting manufacturing process systems in a Good Manufacturing Practice environment and Quality Control laboratories.

Desired Qualifications

  • Prior internship experience is desired.

About the Company

Ultragenyx Pharmaceutical

Develops and commercializes rare-disease therapies

Ultragenyx develops and commercializes therapies for rare and ultra-rare genetic diseases. Its products move from clinical development to FDA approval and market, including burosumab for Tumor Induced Osteomalacia and UX007 for Long-chain Fatty Acid Oxidation Disorders. The company differentiates itself with a diversified pipeline and a strong commitment to uninterrupted patient access, serving a niche, high-need market. Its goal is to translate scientific research into effective, accessible treatments and establish leadership in the rare-disease treatment market.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Novato, CA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Ultragenyx Pharmaceutical

See more jobs